Skip to content
About Us
Overview
Company Leadership
Intrommune R&D
Food Allergies
Oral Mucosal Immunotherapy
INT301 for Peanut Allergy
Media
Press Releases
Events
Intrommune in the News
Investors
Videos
White Paper
Contact Us
Newsletter
Sign up for Intrommune's newsletter and stay informed of company developments.
Press Releases
February 2021
Intrommune Therapeutics Publishes Peanut Allergy and Immunotherapy Report
February 2021
Intrommune Receives IND Clearance From U.S. Food and Drug Administration for INT301
October 2020
Intrommune Therapeutics Strikes Deal with Circuit Clinical
®
October 2020
Recent Peer-Reviewed Publication Supports Immunotherapy for the Treatment of Food Allergies
September 2020
Media Alert: Interest in Peanut Allergy Market Heats up in the Wake of Aimmune/Nestlé Deal
February 2020
Survey Confirms Physician Interest in Peanut Allergy Immunotherapy
January 2020
Intrommune Presenting at Biotech Showcase 2020
About Us
Overview
Company Leadership
Intrommune R&D
Food Allergies
Oral Mucosal Immunotherapy
INT301 for Peanut Allergy
Media
Press Releases
Events
Intrommune in the News
Investors
Videos
White Paper
Contact Us
Investors
Login
Username or email address
*
Password
*
Remember me
Log in
Lost your password?